Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q08426: Variant p.Glu3Lys

Peroxisomal bifunctional enzyme
Gene: EHHADH
Feedback?
Variant information Variant position: help 3 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glutamate (E) to Lysine (K) at position 3 (E3K, p.Glu3Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (E) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In FRTS3; the mutant is mistargeted to mitochondria; results in impaired mitochondrial oxidative phosphorylation and defects in the transport of fluids across the epithelium of renal proximal tubular cells. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 3 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 723 The length of the canonical sequence.
Location on the sequence: help MA E YTRLHNALALIRLRNPPVNA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         MAEYTRLHNALALIRLRNPPVNA

Mouse                         MAEYLRLPHSLAMIRLCNPPVNA

Rat                           MAEYLRLPHSLAMIRLCNPPVNA

Zebrafish                     MARYELVKRSVALITLTNPPVNA
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 723 Peroxisomal bifunctional enzyme
Region 1 – 282 Enoyl-CoA hydratase / isomerase
Alternative sequence 1 – 96 Missing. In isoform 2.



Literature citations
Regulation of cellular metabolism by protein lysine acetylation.
Zhao S.; Xu W.; Jiang W.; Yu W.; Lin Y.; Zhang T.; Yao J.; Zhou L.; Zeng Y.; Li H.; Li Y.; Shi J.; An W.; Hancock S.M.; He F.; Qin L.; Chin J.; Yang P.; Chen X.; Lei Q.; Xiong Y.; Guan K.L.;
Science 327:1000-1004(2010)
Cited for: ACETYLATION AT LYS-165; LYS-171; LYS-346 AND LYS-584; ACTIVITY REGULATION; IDENTIFICATION BY MASS SPECTROMETRY; MUTAGENESIS OF LYS-165; LYS-171; LYS-346 AND LYS-584; Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome.
Klootwijk E.D.; Reichold M.; Helip-Wooley A.; Tolaymat A.; Broeker C.; Robinette S.L.; Reinders J.; Peindl D.; Renner K.; Eberhart K.; Assmann N.; Oefner P.J.; Dettmer K.; Sterner C.; Schroeder J.; Zorger N.; Witzgall R.; Reinhold S.W.; Stanescu H.C.; Bockenhauer D.; Jaureguiberry G.; Courtneidge H.; Hall A.M.; Wijeyesekera A.D.; Holmes E.; Nicholson J.K.; O'Brien K.; Bernardini I.; Krasnewich D.M.; Arcos-Burgos M.; Izumi Y.; Nonoguchi H.; Jia Y.; Reddy J.K.; Ilyas M.; Unwin R.J.; Gahl W.A.; Warth R.; Kleta R.;
N. Engl. J. Med. 370:129-138(2014)
Cited for: VARIANT FRTS3 LYS-3; CHARACTERIZATION OF VARIANT FRTS3 LYS-3; TISSUE SPECIFICITY;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.